Did you know?

Axim Biotechnology Inc. (OTCMKTS:AXIM) has announced that its manufacturing partner Empowered Diagnostics has filed an Emergency Use Authorization (EUA) application with US FDA for ImmunoPass™'s approval. ImmunoPass™ is the company's rapid test kit that measures COVID-19 neutralizing antibody levels to detect neutralizing antibodies in whole blood.Shares of OTCMKTS AXIM opened at $0.02 on Friday. The firm’s 50-day moving average price is $0.03 and its two-hundred day moving average price is $0.03. AXIM Biotechnologies has a 52-week low of ...AXIM Biotechnologies (OTCMKTS: AXIM) Deploys IUL’s State-Of-The-Art Ipeak Readers to Transform the Testing and Diagnosis of Dry Eye Disease (DED) Obtaining adequate samples for tear analysis is a tall order, which requires an effective collection method. The standard method is the use of capillary designs, which,...AXIM® Biotechnologies Develops Novel Dual IgE/MMP-9 Rapid Ophthalmological Diagnostic Test; Files Provisional Patent . December 13, 2022. OTCMKTS: AXIM Biotechnology Patent VISIT WEBSITE Leading Diagnostic Healthcare Company Announces Development of and Provisional Patent Filing on First-of-Its-Kind Point-of-Care Ophthalmological Diagnostic ...Bumble (NASDAQ:BMBL - Free Report) had its target price decreased by Raymond James from $25.00 to $22.00 in a report released on Wednesday morning, Benzinga reports. Raymond James currently has an outperform rating on the stock. Other equities research analysts also recently issued research reports about the stock. Royal Bank of Canada cut their target […]Alternate Health resides in the cannabis sector along with companies like GW Pharmaceuticals (OTCMKTS:GWPRF), AXIM Biotechnologies Inc. (OTCMKTS:AXIM), Canopy Growth Corporation (TSE:WEED), and ...High Performance Beverage Co. Develops New Line Of Hemp Protein Infused Sports Drinks ...Post Views: 1,556 Axim Biotechnologies Inc (OTCMKTS:AXIM), an investment company of Medical Marijuana Inc (OTCMKTS:MJNA), rolled out a rapid diagnostic test to measure the levels of neutralizing antibodies and save the humans from the threat of coronavirus. Diagnostic to overcome coronavirus CEO Dr. Stuart Titus, CEO of Medical Marijuana, said its investment company – Axim […]Click to Enlarge Axim Biotechnologies (OTCMKTS: AXIM) makes a really cool product.It is a biotechnology company based in New York City. The company makes chewing gum that is infused with medicinal ...Post Views: 1,258 Curaleaf Holdings Inc (OTCMKTS: CURLF) recently announced the launch of Cliq by Select, a breakthrough hardware system in vape technology. Hardware technology launched in Oregon, California, and Arizona will be available across the country The Cliq by Select is nothing short of a breakthrough hardware system from its Select brand.Arrowstreet Capital Limited Partnership lowered its stake in shares of VEON Ltd. (NASDAQ:VEON) by 11.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 5,596,621 shares of the Wireless communications provider's stock after selling 723,577 shares during the period. Arrowstreet Capital […]The global economy is reliant on entrepreneurial skills that lead to successful startups. However, most of these brilliant ideas need a capital injection to facilitate productivity. Most entrepreneurs result in financial borrowing under amicable terms with the primary lending institutions such as banks. In recent times, there have been new trends such as seeding and […]CAPRICOR THERAPEUTICS, INC. (NASDAQ:CAPR) Files An 8-K Other EventsItem 8.01 On May 13, 2020, Capricor Therapeutics, Inc. (the "Company") announced positive top-line results from the HOPE-2 trial.

SAN DIEGO, Aug. 03, 2021 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), a leader in the development of diagnostic testing for COVID-19 and cancer, announced today that the Company has signed a Binding Term Sheet to acquire the technology for the testing of Dry Eye …Gladstone Commercial Co. (NASDAQ:GOODO - Get Rating) was the target of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling ...Post Views: 1,941 Generex Biotechnology Corporation (OTCMKTS:GNBT) has such a strong portfolio of immune-oncology assets, diagnostics, and medical devices. An acquisition strategy the company applies from time to time has enabled it to offer end-to-end solutions to the healthcare industry. It has established a powerful network with pharmacies, clinical laboratories, and medical device ...May 23, 2023 · With an extensive background in healthcare operations management and scaling diagnostic companies, Phinney brings valuable expertise to AXIM. In previous roles, he successfully reduced costs, increased capacity, and shortened production time, boosting manufacturing output from 11,000 assays to an impressive 225,000 assays per week.

Axim Biotechnologies Inc (OTCMKTS:AXIM) has been one of our favorites in the MMJ space since the early Fall. That’s when the company’s research trajectory started to get serious traction in the development of a chewing gum delivery system for THC and CBD for the treatment of pain and spasticity asso...Latest News From AXIM Biotechnologies August 1, 2023 AXIM® Biotechnologies Receives Notice of U.S. Patent Allowance for Three Separate Patents Including Its Rapid Point of Care Neutralizing Antibody Test…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. AXIM Biotechnologies (OTCMKTS:AXIM - Get Rating) i. Possible cause: Post Views: 466 Axim Biotechnologies Inc (OTCMKTS:AXIM) has announced that it's.